Ondansetron

NDC 57237-077 · Rising Pharma Holdings, Inc.

Generic nameOndansetron

Dosage formTABLET, ORALLY DISINTEGRATING

RouteORAL

Active ingredient(s)ONDANSETRON

Strength4 mg/1

Pharmacologic classSerotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]

Marketing categoryANDA

Packages

57237-077-01 — 100 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (57237-077-01)

57237-077-10 — 3 BLISTER PACK in 1 CARTON (57237-077-10) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

57237-077-30 — 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (57237-077-30)

57237-077-50 — 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (57237-077-50)

FDA lists these products with the same active ingredient.

50090-4632 — Ondansetron, 51655-008 — Ondansetron, 51655-196 — Ondansetron, 51655-809 — Ondansetron, 51655-913 — Ondansetron, 51662-1246 — ONDANSETRON, 51662-1514 — ONDANSETRON, 55154-3680 — Ondansetron, 55154-4567 — ondansetron, 55154-8339 — Ondansetron, 57237-078 — Ondansetron, 60760-306 — Ondansetron, 60760-654 — Ondansetron, 60760-936 — Ondansetron, 61919-986 — ONDANSETRON, 62135-121 — Ondansetron, 62135-122 — Ondansetron, 62135-878 — Ondansetron, 62135-879 — Ondansetron, 62756-240 — ondansetron, +78 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.